Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia's TGA consults on proposed overhaul of OTC drug guidelines

This article was originally published in SRA

Executive Summary

Australia's Therapeutic Goods Administration is inviting comments on its proposal to substantially revise its guidance document for over-the-counter medicines1. The revisions are being made to clarify the data requirements for submitting OTC medicine applications to the TGA and to provide guidance on OTC drug market authorisation processes that are also currently being reviewed.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel